vs
Side-by-side financial comparison of Caterpillar Inc. (CAT) and Elevance Health (ELV). Click either name above to swap in a different company.
Caterpillar Inc. is the larger business by last-quarter revenue ($85.0B vs $49.7B, roughly 1.7× Elevance Health). On growth, Elevance Health posted the faster year-over-year revenue change (1.8% vs -17.7%). Over the past eight quarters, Caterpillar Inc.'s revenue compounded faster (125.7% CAGR vs 6.5%).
Caterpillar Inc. is an American construction, mining, and other engineering equipment manufacturer. The company is the world's largest manufacturer of construction equipment. In 2018, Caterpillar was ranked number 73 on the Fortune 500 list and number 265 on the Global Fortune 500 list. Caterpillar stock is a component of the Dow Jones Industrial Average.
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon.
CAT vs ELV — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $85.0B | $49.7B |
| Net Profit | — | $547.0M |
| Gross Margin | 89.5% | 88.9% |
| Operating Margin | 3.0% | 0.6% |
| Net Margin | — | 1.1% |
| Revenue YoY | -17.7% | 1.8% |
| Net Profit YoY | — | -74.9% |
| EPS (diluted) | $4.20 | $2.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $85.0B | $49.7B | ||
| Q4 25 | $19.1B | $49.7B | ||
| Q3 25 | $17.6B | $50.7B | ||
| Q2 25 | $16.6B | $49.8B | ||
| Q1 25 | $14.2B | $48.9B | ||
| Q4 24 | $16.2B | $45.4B | ||
| Q3 24 | $16.1B | $45.1B | ||
| Q2 24 | $16.7B | $43.9B |
| Q1 26 | — | $547.0M | ||
| Q4 25 | $2.4B | $547.0M | ||
| Q3 25 | $2.3B | $1.2B | ||
| Q2 25 | $2.2B | $1.7B | ||
| Q1 25 | $2.0B | $2.2B | ||
| Q4 24 | $2.8B | $418.0M | ||
| Q3 24 | $2.5B | $1.0B | ||
| Q2 24 | $2.7B | $2.3B |
| Q1 26 | 89.5% | 88.9% | ||
| Q4 25 | 30.5% | 88.9% | ||
| Q3 25 | 33.8% | 89.4% | ||
| Q2 25 | 34.8% | 89.4% | ||
| Q1 25 | 37.1% | 89.8% | ||
| Q4 24 | 36.3% | 86.8% | ||
| Q3 24 | 37.5% | 88.7% | ||
| Q2 24 | 39.2% | 89.0% |
| Q1 26 | 3.0% | 0.6% | ||
| Q4 25 | 13.9% | 0.6% | ||
| Q3 25 | 17.3% | 2.6% | ||
| Q2 25 | 17.3% | 4.9% | ||
| Q1 25 | 18.1% | 6.5% | ||
| Q4 24 | 18.0% | 1.5% | ||
| Q3 24 | 19.5% | 3.1% | ||
| Q2 24 | 20.9% | 6.3% |
| Q1 26 | — | 1.1% | ||
| Q4 25 | 12.5% | 1.1% | ||
| Q3 25 | 13.0% | 2.3% | ||
| Q2 25 | 13.2% | 3.5% | ||
| Q1 25 | 14.1% | 4.5% | ||
| Q4 24 | 17.2% | 0.9% | ||
| Q3 24 | 15.3% | 2.3% | ||
| Q2 24 | 16.1% | 5.2% |
| Q1 26 | $4.20 | $2.56 | ||
| Q4 25 | $5.11 | $2.56 | ||
| Q3 25 | $4.88 | $5.32 | ||
| Q2 25 | $4.62 | $7.72 | ||
| Q1 25 | $4.20 | $9.61 | ||
| Q4 24 | $5.76 | $1.88 | ||
| Q3 24 | $5.06 | $4.36 | ||
| Q2 24 | $5.48 | $9.85 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.0M | $9.5B |
| Total DebtLower is stronger | $0 | $31.9B |
| Stockholders' EquityBook value | $21.3M | $43.9B |
| Total Assets | $98.6M | $121.5B |
| Debt / EquityLower = less leverage | 0.00× | 0.73× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $10.0M | $9.5B | ||
| Q4 25 | $10.0B | $9.5B | ||
| Q3 25 | $7.5B | $8.7B | ||
| Q2 25 | $5.4B | $8.6B | ||
| Q1 25 | $3.6B | $7.5B | ||
| Q4 24 | $6.9B | $8.3B | ||
| Q3 24 | $5.6B | $7.9B | ||
| Q2 24 | $4.3B | $6.5B |
| Q1 26 | $0 | $31.9B | ||
| Q4 25 | — | $31.9B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $30.9B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $21.3M | $43.9B | ||
| Q4 25 | $21.3B | $43.9B | ||
| Q3 25 | $20.7B | $44.0B | ||
| Q2 25 | $18.7B | $43.7B | ||
| Q1 25 | $18.1B | $42.5B | ||
| Q4 24 | $19.5B | $41.3B | ||
| Q3 24 | $19.4B | $43.8B | ||
| Q2 24 | $17.1B | $42.2B |
| Q1 26 | $98.6M | $121.5B | ||
| Q4 25 | $98.6B | $121.5B | ||
| Q3 25 | $93.7B | $122.7B | ||
| Q2 25 | $90.3B | $121.9B | ||
| Q1 25 | $85.0B | $119.7B | ||
| Q4 24 | $87.8B | $116.9B | ||
| Q3 24 | $86.3B | $116.5B | ||
| Q2 24 | $83.3B | $113.0B |
| Q1 26 | 0.00× | 0.73× | ||
| Q4 25 | — | 0.73× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.75× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
